Tocilizumab'S Efficacy In Patients With Coronavirus Disease 2019 (Covid-19) Is Determined By The Presence Of Cytokine Storm

We read with great interest the research article written by Borku Uysal B et al which is in accordance with the so far accumulating knowledge that tocilizumab is an effective treatment for COVID-19 cytokine storm syndrome (CSS). This article is protected by copyright. All rights reserved.